BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
BeyondSpring Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.51−0.05 (-8.28%)
Close on Oct 19, 2026
- Market cap
- $21.09M
- P/E (TTM)
- –
- Dividend yield
- –
BeyondSpring Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Plinabulin Pipeline [Member] | – | – | $0 | $0 | $0 | $0 | – | – | – | – | – | – |
| TPD Platform [Member] | – | – | $1.75M | $1.35M | $1.35M | $180.00K | – | – | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Plinabulin Pipeline [Member] | – | – | -$15.32M | -$29.53M | -$61.81M | -$62.70M | – | – | – | – | – |
| TPD Platform [Member] | – | – | -$8.03M | -$7.95M | -$4.67M | -$1.54M | – | – | – | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of BeyondSpring's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.